Prognostic factors in patients with operable breast cancer who received neoadjuvant chemotherapy

被引：0
|
作者：
Horiguchi, J. [1 ]
Takata, D. [1 ]
Nagaoka, R. [1 ]
Fujii, T. [1 ]
Sato, A. [1 ]
Tokiniwa, H. [1 ]
Higuchi, T. [1 ]
Uchida, S. [1 ]
Tsuboi, M. [1 ]
Yajima, R. [1 ]
Kikuchi, M. [1 ]
Ino, Y. [2 ]
Oyama, T. [3 ]
机构：
[1] Gunma Univ Hosp, Breast & Endocrine Surg, Maebashi, Gunma, Japan
[2] Kusunoki Hosp, Surg, Fujioka, Japan
[3] Gunma Univ Hosp, Pathol, Maebashi, Gunma, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
337
引用
收藏
页码：S94 / S94
页数：1
相关论文
共 50 条
  • [31] Prognostic factors in patients who received end-of-life chemotherapy for advanced cancer
    Shuji Hiramoto
    Tomoko Tamaki
    Kengo Nagashima
    Tetsuo Hori
    Ayako Kikuchi
    Akira Yoshioka
    Akira Inoue
    International Journal of Clinical Oncology, 2019, 24 : 454 - 459
  • [32] Conservative surgery after neoadjuvant chemotherapy in patients with operable breast cancer
    Franceschini, Gianluca
    Di Leone, Alba
    Natale, Maria
    Sanchez, Martin Aleandro
    Masett, Riccardo
    ANNALI ITALIANI DI CHIRURGIA, 2018, 89 (03) : 290 - 290
  • [33] Prognostic Factors in Triple Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Wada, N.
    Yoneyama, K.
    Yamauchi, C.
    Fujii, S.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S140 - S140
  • [34] The impact of obesity on response to neoadjuvant chemotherapy in operable breast cancer patients
    Lee, H. Y.
    Jung, S. P.
    Kim, S.
    Kim, H. Y.
    Bae, J. W.
    Lee, J. B.
    CANCER RESEARCH, 2013, 73
  • [35] Prognostic Significance of a Complete Response on Breast MRI in Patients Who Received Neoadjuvant Chemotherapy According to the Molecular Subtype
    Ko, Eun Sook
    Han, Heon
    Han, Boo-Kyung
    Kim, Sun Mi
    Kim, Rock Bum
    Lee, Gyeong-Won
    Park, Yeon Hee
    Nam, Seok Jin
    KOREAN JOURNAL OF RADIOLOGY, 2015, 16 (05) : 986 - 995
  • [36] Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer
    Ellis, P
    Smith, I
    Ashley, S
    Walsh, G
    Ebbs, S
    Baum, M
    Sacks, N
    McKinna, J
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) : 107 - 114
  • [37] Predictive factors of pathological complete response by neoadjuvant chemotherapy for operable breast cancer
    Ishikawa, Takashi
    Shimizu, Daisuke
    Sasaki, Takashi
    Morita, Satoshi
    Tanabe, Mikiko
    Ota, Ikuko
    Kawachi, Kae
    Chishima, Takashi
    Ichikawa, Yasushi
    Endo, Itaru
    CANCER RESEARCH, 2011, 71
  • [38] Prognostic value of serum lipid levels in breast cancer patients who received neoadjuvant chemotherapy: A retrospective exploratory analysis of the prospective cohort
    Chen, Xinru
    Yin, Wenjin
    Zhao, Yingying
    Lu, Jinsong
    CANCER RESEARCH, 2024, 84 (09)
  • [39] Prognostic significance of pathological complete response following neoadjuvant chemotherapy for operable breast cancer
    Kawajiri, Hidemi
    Takashima, Tsutomu
    Aomatsu, Naoki
    Kashiwagi, Shinichiro
    Noda, Satoru
    Onoda, Naoyoshi
    Ishikawa, Tetsurou
    Hirakawa, Kosei
    ONCOLOGY LETTERS, 2014, 7 (03) : 663 - 668
  • [40] The impact of time to surgery in different tumor subtypes in breast cancer patients who received neoadjuvant chemotherapy
    Altundag, Kadri
    JOURNAL OF BUON, 2021, 26 (01): : 280 - 280
12345